These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 8862963

  • 1. Adverse effects of thyroid hormone preparations and antithyroid drugs.
    Bartalena L, Bogazzi F, Martino E.
    Drug Saf; 1996 Jul; 15(1):53-63. PubMed ID: 8862963
    [Abstract] [Full Text] [Related]

  • 2. [Thyrostatic treatment and its adverse effects].
    Dokupilová A, Payer J.
    Vnitr Lek; 2013 Nov; 59(11):989-95. PubMed ID: 24279443
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacotherapy of hyperthyreosis--adverse drug reactions].
    Perger L, Bürgi U, Fattinger K.
    Ther Umsch; 2011 Jun; 68(6):303-8. PubMed ID: 21656488
    [Abstract] [Full Text] [Related]

  • 4. Increased risk for thionamide-induced agranulocytosis in elderly patients: a case presentation and literature review.
    Bukhari S, Khan M, Kumar N, Mohan V.
    BMJ Case Rep; 2017 Jul 17; 2017():. PubMed ID: 28716776
    [Abstract] [Full Text] [Related]

  • 5. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
    Dai W, Zhang J, Zhan Z, Xu B, Jin H.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun 17; 20(3):226-9. PubMed ID: 11367711
    [Abstract] [Full Text] [Related]

  • 6. Hepatotoxicity from antithyroid drugs.
    Vitug AC, Goldman JM.
    Horm Res; 1985 Jun 17; 21(4):229-34. PubMed ID: 4007783
    [Abstract] [Full Text] [Related]

  • 7. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.
    Akmal A, Kung J.
    Expert Opin Drug Saf; 2014 Oct 17; 13(10):1397-406. PubMed ID: 25156887
    [Abstract] [Full Text] [Related]

  • 8. Carbimazole-induced agranulocytosis--a report of 2 recent cases.
    Tavintharan S, Rajasoorya C, Chew LS.
    Singapore Med J; 1997 Sep 17; 38(9):386-7. PubMed ID: 9407764
    [Abstract] [Full Text] [Related]

  • 9. Antithyroid drug-induced aplastic anemia.
    Thomas D, Moisidis A, Tsiakalos A, Alexandraki K, Syriou V, Kaltsas G.
    Thyroid; 2008 Oct 17; 18(10):1043-8. PubMed ID: 18816182
    [Abstract] [Full Text] [Related]

  • 10. [Side effects of antithyroid therapy of hyperthyroidism. A study of 1256 continuously treated patients].
    Meyer-Gessner M, Benker G, Olbricht T, Windeck R, Cissewski K, Reiners C, Reinwein D.
    Dtsch Med Wochenschr; 1989 Feb 03; 114(5):166-71. PubMed ID: 2464468
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years.
    Yang J, Zhu YJ, Zhong JJ, Zhang J, Weng WW, Liu ZF, Xu Q, Dong MJ.
    Thyroid; 2016 May 03; 26(5):627-33. PubMed ID: 26867063
    [Abstract] [Full Text] [Related]

  • 12. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK.
    Pearce SH.
    Clin Endocrinol (Oxf); 2004 Nov 03; 61(5):589-94. PubMed ID: 15521961
    [Abstract] [Full Text] [Related]

  • 13. Antithyroid drugs.
    Cooper DS.
    N Engl J Med; 2005 Mar 03; 352(9):905-17. PubMed ID: 15745981
    [No Abstract] [Full Text] [Related]

  • 14. Safety of medications and hormones used in the treatment of pediatric thyroid disorders.
    Beck-Peccoz P, Persani L, LaFranchi S.
    Pediatr Endocrinol Rev; 2004 Nov 03; 2 Suppl 1():124-33. PubMed ID: 16456491
    [Abstract] [Full Text] [Related]

  • 15. HLA-B*38:02:01 predicts carbimazole/methimazole-induced agranulocytosis.
    Cheung CL, Sing CW, Tang CS, Cheng VK, Pirmohamed M, Choi CH, Hung CS, Lau EY, Lee KF, Mak MW, Leung JY, Wong TW, Ho AY, Chan KW, Hung V, Tam V, Siu SC, Pang HK, Wat WZ, Lee HH, Chung CT, Hue RS, Sham PC, Cheung BM, Wong IC, Tan KC, Kung A.
    Clin Pharmacol Ther; 2016 May 03; 99(5):555-61. PubMed ID: 26599303
    [Abstract] [Full Text] [Related]

  • 16. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.
    Bowman P, Osborne NJ, Sturley R, Vaidya B.
    QJM; 2012 Feb 03; 105(2):189-93. PubMed ID: 21258054
    [Abstract] [Full Text] [Related]

  • 17. [Antithyroid drug-induced agranulocytosis. A rare but dreaded condition].
    Lehtihet M, Zedenius J, Helldén A, Axelsson R, Calissendorff J.
    Lakartidningen; 2012 Feb 03; 106(41):2607-8, 2610-1. PubMed ID: 19927925
    [No Abstract] [Full Text] [Related]

  • 18. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E, Pinchera A, Capiferri R, Macchia E, Sardano G, Bartalena L, Mazzanti F, Baschieri L.
    J Clin Endocrinol Metab; 1976 Sep 03; 43(3):543-9. PubMed ID: 821960
    [Abstract] [Full Text] [Related]

  • 19. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM.
    Am Fam Physician; 1982 Sep 03; 26(3):183-8. PubMed ID: 6180620
    [Abstract] [Full Text] [Related]

  • 20. Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
    Stege R.
    Acta Chir Scand Suppl; 1980 Sep 03; 501():1-130. PubMed ID: 6163270
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.